Uncovering Cryptic Glycan Markers in Multiple Sclerosis (MS) and Experimental Autoimmune Encephalomyelitis (EAE)
- 11 March 2014
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 75 (3) , 172-188
Abstract
Preclinical Research Using an integrated antigen microarray approach, we observed epitope‐spreading of autoantibody responses to a variety of antigenic structures in the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS) and in the serum of mice with experimental autoimmune encephalomyelitis (EAE). These included previously described protein‐ and lipid‐based antigenic targets and newly discovered autoimmunogenic sugar moieties, notably, autoantibodies specific for the oligomannoses in both MS patient CSF and the sera of mice with EAE. These glycans are often masked by other sugar moieties and belong to a class of cryptic autoantigens. We further determined that these targets are highly expressed on multiple cell types in MS and EAE lesions. Co‐immunization of SJL/J mice with a Man9‐KLH conjugate at the time of EAE induction elicited highly significant levels of anti‐Man9‐cluster autoantibodies. Nevertheless, this anti‐glycan autoantibody response was associated with a significantly reduced clinical severity of EAE. The potential of these cryptic glycan markers and targeting antibodies for diagnostic and therapeutic interventions of neurological disorders has yet to be explored.Keywords
This publication has 48 references indexed in Scilit:
- A sensitive gel-based global O-glycomics approach reveals high levels of mannosyl glycans in the high mass region of the mouse brain proteomeBiological Chemistry, 2012
- Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and miceJournal of Experimental Medicine, 2012
- O-Linked N,N′-Diacetyllactosamine (LacdiNAc)-modified Glycans in Extracellular Matrix Glycoproteins Are Specifically Phosphorylated at Subterminal N-AcetylglucosamineJournal of Biological Chemistry, 2012
- Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing–remitting multiple sclerosisJournal of Neuroimmunology, 2012
- Broad neutralization coverage of HIV by multiple highly potent antibodiesNature, 2011
- Enhanced Immune Recognition of Cryptic Glycan Markers in Human TumorsCancer Research, 2009
- A Glycoconjugate Antigen Based on the Recognition Motif of a Broadly Neutralizing Human Immunodeficiency Virus Antibody, 2G12, Is Immunogenic but Elicits Antibodies Unable To Bind to the Self Glycans of gp120Journal of Virology, 2008
- Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoVPhysiological Genomics, 2004
- Carbohydrate microarrays for the recognition of cross-reactive molecular markers of microbes and host cellsNature Biotechnology, 2002
- Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous SystemCell, 1996